Physician profile
Meredith Cook
NPI 1366958555
$4,432.39
in general payments reported to CMS, 2019-2025
17 companies · $2,082 in 2025
The $2,082 reported for 2025 was more than what 91% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $237 · 2022: $374 · 2023: $635 · 2024: $1,105 · 2025: $2,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,821.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $950.16 | 2021-2025 | Ocaliva |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $864.50 | 2021-2025 | Xifaxan |
| Gilead Sciences, INC. | $813.37 | 2023-2025 | Livdelzi |
| Madrigal Pharmaceuticals | $517.99 | 2024-2025 | Rezdiffra, Resmetirom |
| Ipsen Biopharmaceuticals, INC | $400.54 | 2024-2025 | Iqirvo, Bylvay |
| Mirum Pharmaceuticals, INC. | $211.54 | 2024-2025 | Livmarli |
| Orphalan INC | $170.63 | 2023-2025 | Cuvrior |
| Boston Scientific Corporation | $140.79 | 2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Novo Nordisk INC | $129.00 | 2025 | Wegovy |
| Glaxosmithkline, LLC. | $57.09 | 2025 | |
| Eton Pharmaceuticals, INC. | $44.91 | 2025 | Khindivi, Alkindi, Increlex |
| Albireo Pharma, INC. | $33.62 | 2022-2023 | Bylvay |
| Takeda Pharmaceuticals U.S.A., INC. | $30.33 | 2024 | Vpriv |
| Astrazeneca Pharmaceuticals LP | $24.40 | 2025 | |
| Vbi Vaccine (Delaware) INC. | $16.22 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $13.72 | 2022 | |
| Travere Therapeutics, INC. | $13.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.